Breaking News Instant updates and real-time market news.

RMTI

Rockwell Medical

08:34
09/13/17
09/13
08:34
09/13/17
08:34

Rockwell Medical updates progress on Calcitriol commercial launch

Rockwell Medical provided an update on the commercial launch of Calcitriol, stating that product stability data for manufacturing approval is suitable for submission to the FDA. The company plans to submit its chemistry, manufacturing and controls, or CMC, post-approval drug manufacturing supplement to the FDA at the end of September 2017, as guided. As a result, the company anticipates Calcitriol to be commercially available in the U.S. approximately 30 days after the CMC submission, provided the FDA has no further requests. Calcitriol is Rockwell's FDA approved active Vitamin D injection for the management of hypocalcemia in patients undergoing chronic renal dialysis.

  • 13

    Sep

RMTI Rockwell Medical

11/08/16
11/08/16
DOWNGRADE
Target $5

Underperform
Rockwell Medical downgraded on lack of Triferic sales at BofA/Merrill
As previously reported, BofA/Merrill downgraded Rockwell Medical to Underperform from Neutral and lowered its price target to $5 from $9. Analyst Tazeen Ahmad said Q3 results proved little visibility into when Triferic may launch, and as a result, removed his 2016 sales forecasts and ramp rate. Ahmad now assumes peak Triferic sales of $104M in 2024, versus $153M previously and notes Calcitriol manufacturing issues have resulted in a delayed launch of that product.
11/08/16
MSCO
11/08/16
NO CHANGE
Target $2
MSCO
Underweight
Rockwell Medical price target cut to $2 from $3 at Morgan Stanley
08/14/17
IFSG
08/14/17
INITIATION
Target $11
IFSG
Strong Buy
Rockwell Medical initiated with a Strong Buy at IFS Securities
IFS Securities analyst David Bouchey started Rockwell Medical with a Strong Buy and $11 price target. The analyst believes the company is "headed for a massive surge in revenues" due to Triferic and Calcitriol.
08/29/17
08/29/17
NO CHANGE

Richmond Brothers says Rockwell Medical CEO should be replaced immediately
Richmond Brothers, owner of 10.8% of Rockwell Medical's outstanding shares, disclosed last night in a regulatory filing that it has concluded the company "continues to blatantly disregard the will" of its shareholders. Richmond added that it has "lost all confidence" in Chairman and CEO Robert Chioini's ability to effectively oversee the company and drive shareholder value. The fund stated, "Given the Issuer's significant financial and stock price underperformance and inability to monetize promising drugs Triferic and Calcitriol under Mr. Chioini's leadership, the Reporting Persons do not believe Mr. Chioini has proven himself capable of successfully leading the Company forward and are convinced that he should be replaced as Chairman and CEO immediately. To the extent this does not happen , the Reporting Persons note that Mr. Chioini, along with long-standing director Patrick J. Bagley, will be up for election at the 2018 annual meeting of shareholders, at which the Reporting Persons intend to nominate a competing slate of director candidates. Separate and apart from the Ravich Parties, the Richmond Parties intend to engage in discussions with shareholders of the Issuer, private equity firms, potential sources of financing and other interested parties regarding the Issuer's capital allocation, corporate governance and other means to enhance shareholder value, including a possible sale of the Issuer. While the Richmond Parties are not advocating for a sale of the Issuer at this time, the Richmond Parties believe there are multiple paths to value creation and that all paths should be evaluated. To the extent there is strategic interest in the Issuer, the Richmond Parties invite potential strategic acquirers to contact the Richmond Parties."

TODAY'S FREE FLY STORIES

AGCO

Agco

$73.31

0.34 (0.47%)

06:41
09/21/17
09/21
06:41
09/21/17
06:41
Recommendations
Agco analyst commentary  »

Agco long-term margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

06:41
09/21/17
09/21
06:41
09/21/17
06:41
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDX

Market Vector Gold Miners

$23.50

-0.35 (-1.47%)

06:41
09/21/17
09/21
06:41
09/21/17
06:41
Technical Analysis
Market Vector Gold Miners: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$24.32

0.12 (0.50%)

06:40
09/21/17
09/21
06:40
09/21/17
06:40
Periodicals
GE shutting down corporate jet fleet in bid to cut costs, WSJ reports »

GE is planning to shut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

GLD

SPDR Gold Trust

$123.62

-1 (-0.80%)

06:40
09/21/17
09/21
06:40
09/21/17
06:40
Technical Analysis
SPDR Gold Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUGT

Direxion Gold Miners Bull

$33.69

-1.66 (-4.70%)

06:40
09/21/17
09/21
06:40
09/21/17
06:40
Technical Analysis
Direxion Gold Miners Bull: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$18.82

-1.03 (-5.19%)

06:39
09/21/17
09/21
06:39
09/21/17
06:39
Technical Analysis
Direxion Daily Jr Gld Mnrs Bull 3X Shrs: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUST

Direxion Daily Gold Miners Bear 3X ETF

$24.34

1.09 (4.69%)

06:39
09/21/17
09/21
06:39
09/21/17
06:39
Technical Analysis
Direxion Daily Gold Miners Bear 3X ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$54.48

2.67 (5.15%)

06:38
09/21/17
09/21
06:38
09/21/17
06:38
Technical Analysis
Direxion Daily Junior Gold Miners Index Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VXX

iPath S&P 500 VIX Short-Term Futures

$40.98

0.07 (0.17%)

06:37
09/21/17
09/21
06:37
09/21/17
06:37
Technical Analysis
iPath S&P 500 VIX Short-Term Futures: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XIV

VelocityShares Daily Inverse VIX Short-Term ETN

$93.36

-0.23 (-0.25%)

06:37
09/21/17
09/21
06:37
09/21/17
06:37
Technical Analysis
VelocityShares Daily Inverse VIX Short-Term ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TVIX

VelocityShares Daily 2x VIX Short-Term ETN

$12.45

0.06 (0.48%)

06:36
09/21/17
09/21
06:36
09/21/17
06:36
Technical Analysis
VelocityShares Daily 2x VIX Short-Term ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVXY

ProShares Short VIX Short-Term Futures

$89.64

-0.09 (-0.10%)

06:36
09/21/17
09/21
06:36
09/21/17
06:36
Technical Analysis
ProShares Short VIX Short-Term Futures: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALV

Autoliv

$122.59

1.04 (0.86%)

06:36
09/21/17
09/21
06:36
09/21/17
06:36
Recommendations
Autoliv analyst commentary  »

Autoliv price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

USO

United States Oil Fund

$10.24

0.13 (1.29%)

06:35
09/21/17
09/21
06:35
09/21/17
06:35
Technical Analysis
United States Oil Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOP

SPDR Oil Exploration and Production Fund

$32.86

0.68 (2.11%)

06:35
09/21/17
09/21
06:35
09/21/17
06:35
Technical Analysis
SPDR Oil Exploration and Production Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$21.73

0.61 (2.89%)

06:34
09/21/17
09/21
06:34
09/21/17
06:34
Technical Analysis
VelocityShares 3x Inv Natural Gas ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UGAZ

VelocityShares 3x Long Natural Gas ETN

$13.20

-0.36 (-2.65%)

06:34
09/21/17
09/21
06:34
09/21/17
06:34
Technical Analysis
VelocityShares 3x Long Natural Gas ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

$13.74

0.62 (4.73%)

, NVDA

Nvidia

$185.84

-1.51 (-0.81%)

06:34
09/21/17
09/21
06:34
09/21/17
06:34
Recommendations
AMD, Nvidia, Tesla analyst commentary  »

Tesla partnership would…

AMD

AMD

$13.74

0.62 (4.73%)

NVDA

Nvidia

$185.84

-1.51 (-0.81%)

TSLA

Tesla

$373.91

-1.19 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

EWZ

MSCI Brazil Index

$43.19

0.13 (0.30%)

06:34
09/21/17
09/21
06:34
09/21/17
06:34
Technical Analysis
MSCI Brazil Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFA

iShares MSCI EAFE Index Fund

$68.32

-0.15 (-0.22%)

06:33
09/21/17
09/21
06:33
09/21/17
06:33
Technical Analysis
iShares MSCI EAFE Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNK

SPDR Barclays High Yield Bond

$37.21

-0.01 (-0.03%)

06:33
09/21/17
09/21
06:33
09/21/17
06:33
Technical Analysis
SPDR Barclays High Yield Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJB

ProShares Short High Yield

$23.19

0.0092 (0.04%)

06:32
09/21/17
09/21
06:32
09/21/17
06:32
Technical Analysis
ProShares Short High Yield: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AUO

AU Optronics

$4.19

-0.03 (-0.71%)

06:32
09/21/17
09/21
06:32
09/21/17
06:32
Periodicals
AU Optronics to continue 'smart investment' policy, DigiTimes reports »

AU Optronics Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HYG

iShares iBoxx $ High Yield Corporate Bond

$88.45

-0.01 (-0.01%)

06:32
09/21/17
09/21
06:32
09/21/17
06:32
Technical Analysis
iShares iBoxx $ High Yield Corporate Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.